Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).

Bar-On ES, Goldberg E, Hellmann S, Leibovici L.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD005530. doi: 10.1002/14651858.CD005530.pub3. Review.

PMID:
22513932
2.

Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).

Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD005530. doi: 10.1002/14651858.CD005530.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD005530.

PMID:
19588375
3.

Hepatitis B vaccine booster dose: low-dose recombinant hepatitis B vaccines as a booster dose.

Bryan JP, MacArthy P, Rudock A, Fogarty JP, Dowd H, Legters LJ, Perine PL.

Am J Infect Control. 1997 Jun;25(3):215-22.

PMID:
9202817
4.

Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine.

Mulder AM, Carragher B, Towne V, Meng Y, Wang Y, Dieter L, Potter CS, Washabaugh MW, Sitrin RD, Zhao Q.

PLoS One. 2012;7(4):e33235. doi: 10.1371/journal.pone.0033235. Epub 2012 Apr 6.

5.
6.
8.

Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.

Akbar SM, Chen S, Al-Mahtab M, Abe M, Hiasa Y, Onji M.

Antiviral Res. 2012 Oct;96(1):59-64. doi: 10.1016/j.antiviral.2012.07.011. Epub 2012 Aug 1.

PMID:
22884884
10.

Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy.

Zanetti A, Parlato A, Romanò L, Desole MG, Ferrera G, Giurdanella F, Zuliani M, Richard P, Thomas S, Fiquet A.

Vaccine. 2012 Aug 24;30(39):5770-5. doi: 10.1016/j.vaccine.2012.06.078. Epub 2012 Jul 9.

PMID:
22789511
12.

Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.

Shinefield H, Black S, Thear M, Coury D, Reisinger K, Rothstein E, Xu J, Hartzel J, Evans B, Digilio L, Schödel F, Brown ML, Kuter B; 013 Study Group for ProQuad.

Pediatr Infect Dis J. 2006 Apr;25(4):287-92.

PMID:
16567978
13.

Global reduction of cervical cancer with human papillomavirus vaccines: insights from the hepatitis B virus vaccine experience.

Heffernan ME, Garland SM, Kane MA.

Sex Health. 2010 Sep;7(3):383-90. doi: 10.1071/SH09134.

PMID:
20719231
15.

Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD).

Niu MT, Rhodes P, Salive M, Lively T, Davis DM, Black S, Shinefield H, Chen RT, Ellenberg SS.

J Clin Epidemiol. 1998 Jun;51(6):503-10.

PMID:
9635999
16.

Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age.

Trofa AF, Klein NP, Paul IM, Michaels MG, Goessler M, Chandrasekaran V, Blatter M.

Pediatr Infect Dis J. 2011 Sep;30(9):e164-9. doi: 10.1097/INF.0b013e31821b8a7d.

PMID:
21494175
17.

Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.

Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D.

Pediatrics. 2006 Sep;118(3):e602-9.

PMID:
16950952
18.

Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.

Vesikari T, Joensuu J, Baer M, Käyhty H, Olander RM, Sormunen H, Miettinen A, Ward RL, Guillot T.

Acta Paediatr. 1999 May;88(5):513-20.

PMID:
10426173
19.

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines.

Leroux-Roels G, Desombere I, Cobbaut L, Petit MA, Desmons P, Hauser P, Delem A, De Grave D, Safary A.

Vaccine. 1997 Nov;15(16):1732-6.

PMID:
9364675
20.

Hepatitis B third-generation vaccines: improved response and conventional vaccine non-response--evidence for genetic basis in humans.

McDermott AB, Cohen SB, Zuckerman JN, Madrigal JA.

J Viral Hepat. 1998 Nov;5 Suppl 2:9-11.

PMID:
9857354

Supplemental Content

Support Center